Literature DB >> 10087321

Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.

H Hisatomi1, K Nagao, T Kanamaru, H Endo, M Tomimatsu, K Hikiji.   

Abstract

This study investigated the relationship between the levels of human telomerase reverse transcriptase (hTERT) mRNA and that of telomerase activity in hepatocellular carcinoma (HCC). A significant correlation between hTERT mRNA expression and telomerase activity by transfecting the gene encoding hTERT into telomerase-negative human fibroblast cells has clearly been demonstrated. However, the relationship between levels of telomerase activity and that of hTERT mRNA has yet to be elucidated. In this study, the levels of hTERT mRNA were analyzed in 24 HCC patients by real-time PCR. And the intensity of telomerase activity was analyzed by fluorescence-based TRAP method. The difference of hTERT mRNA level was highly significant between tumor tissues and non-cancerous liver tissues. And there were significant correlations between the levels of hTERT mRNA and that of telomerase activity (r=0.751) in tumor tissues. We observed a strong correlation between levels of hTERT mRNA and that of telomerase activity in HCC. Our results suggest that the levels of hTERT mRNA would be useful in genetic diagnostic tests, instead of telomerase activity, to screen at-risk patients of HCC in human liver tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087321     DOI: 10.3892/ijo.14.4.727

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.

Authors:  Matthias Krams; Barbara Hero; Frank Berthold; Reza Parwaresch; Dieter Harms; Pierre Rudolph
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Feasibility of human telomerase reverse transcriptase mRNA expression in individual blastomeres as an indicator of early embryo development.

Authors:  Chia-Woei Wang; Ding-Shyan Yao; Shang-Gwo Horng; Hsiao-Chen Chiu; Chun-Kai Chen; Chyi-Long Lee; Hong-Yuan Huang; Hsin-Shih Wang; Yung-Kuei Soong; Chia C Pao
Journal:  J Assist Reprod Genet       Date:  2004-05       Impact factor: 3.412

3.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

4.  Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.

Authors:  R Akeshima; J Kigawa; M Takahashi; T Oishi; Y Kanamori; H Itamochi; M Shimada; S Kamazawa; S Sato; N Terakawa
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

5.  Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.

Authors:  N Toshikuni; K Nouso; T Higashi; H Nakatsukasa; T Onishi; T Kaneyoshi; Y Kobayashi; K Kariyama; K Yamamoto; T Tsuji
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.